StockWatch
·
Petrochemicals
Quarterly Result6 Nov 2026, 01:57 pm

Manali Petro Q2 FY27: Consol PAT Jumps 250% YoY to ₹63.5 Cr as OPM Expands to ~20%

AI Summary

Manali Petrochemicals' consolidated Q2 FY27 (quarter ended 30-Sep-26) revenue rose 59.5% YoY to ₹395.57 Cr and PAT rose 249.9% YoY to ₹63.50 Cr — adjusted to ~+234% after excluding a ₹0.98 Cr one-off exceptional expense booked in the year-ago quarter — with OPM expanding to ~20.0% from 7.79% and NPM to 15.32% from 6.96%. No analyst consensus or management guidance exists for this quarter (confirmed via search: no formal Street estimates or company outlook on record for Manali Petrochemicals), so the print cannot be benchmarked against external expectations and stands on its own against last year's base. Sequentially, PAT was effectively flat (-1.3% QoQ from ₹64.36 Cr) even as revenue grew 44.0% QoQ, because OPM compressed from Q1 FY27's 30.14% to ~20.0% — propylene glycol/propylene oxide economics are spread-driven rather than volume-driven, so a bigger topline did not carry through to the bottom line this quarter. Cost of materials consumed rose to ₹217.46 Cr (55% of revenue) from ₹168.25 Cr in Q1, outpacing the 44% revenue growth and compressing the spread. Consolidated figures (primary) run ~₹10 Cr ahead of standalone PAT of ₹53.47 Cr; the gap is explained almost entirely by the two overseas subsidiaries under AMCHEM Speciality Chemicals (Singapore), which contributed a combined ₹9.78 Cr PAT this quarter per the auditors' report. Note the comparable base a year ago still included Notedome Limited (UK) and Notedome Europe GmbH, divested in November 2025, so the consolidated perimeter itself has changed YoY. This quarter's disclosed developments were administrative (results approved 6-Nov, insider-trading window closure, a September exchange clarification on a price surge) with no operational catalysts; the open items remain the pending Tamil Nadu leasehold-land renewal (lease expired June 2017) and an ₹11.80 Cr Cyclone Michaung insurance claim still carried as a receivable, both repeated as emphasis-of-matter by the auditors. No management press release was available to cross-check the company's own framing of the quarter.

Key Highlights

  • Consolidated PAT ₹63.50 Cr, up 249.9% YoY (vs ₹18.15 Cr) but down 1.3% QoQ from ₹64.36 Cr — a sequential plateau after Q1's exceptional print.
  • Consolidated revenue ₹395.57 Cr, up 59.5% YoY and 44.0% QoQ from ₹248.04 Cr and ₹274.72 Cr respectively.
  • OPM expanded to ~20.0% from 7.79% YoY but compressed from Q1 FY27's 30.14% — spread-driven margin typical of propylene glycol/oxide economics.
  • NPM at 15.32% vs 6.96% YoY, down from 22.31% QoQ.
  • Adjusted YoY PAT growth ~+234% excluding a ₹0.98 Cr one-off exceptional expense in the year-ago quarter — underlying growth remains very strong, not a base-effect artifact.
  • Consolidated PAT runs ~₹10 Cr ahead of standalone (₹53.47 Cr); overseas AMCHEM-Singapore subsidiaries contributed ₹9.78 Cr PAT this quarter.
  • EPS ₹3.69 (consolidated, not annualised) vs ₹1.06 YoY and ₹3.74 QoQ.